Current approaches to the management of brain metastases

JH Suh, R Kotecha, ST Chao, MS Ahluwalia… - Nature reviews Clinical …, 2020 - nature.com
Brain metastases are a very common manifestation of cancer that have historically been
approached as a single disease entity given the uniform association with poor clinical …

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

AA Aizer, N Lamba, MS Ahluwalia, K Aldape… - Neuro …, 2022 - academic.oup.com
Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is
known about brain metastases than cancer-related entities of similar incidence. Advances in …

Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001

PD Brown, V Gondi, S Pugh, WA Tome… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Radiation dose to the neuroregenerative zone of the hippocampus has been
found to be associated with cognitive toxicity. Hippocampal avoidance (HA) using intensity …

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC· 3): a multicentre …

PD Brown, KV Ballman, JH Cerhan… - The Lancet …, 2017 - thelancet.com
Background Whole brain radiotherapy (WBRT) is the standard of care to improve intracranial
control following resection of brain metastasis. However, stereotactic radiosurgery (SRS) to …

Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial

PD Brown, K Jaeckle, KV Ballman, E Farace… - Jama, 2016 - jamanetwork.com
Importance Whole brain radiotherapy (WBRT) significantly improves tumor control in the
brain after stereotactic radiosurgery (SRS), yet because of its association with cognitive …

Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species

P Ma, H Xiao, C Yu, J Liu, Z Cheng, H Song… - Nano …, 2017 - ACS Publications
Reactive oxygen species (ROS) plays a key role in therapeutic effects as well as side effects
of platinum drugs. Cisplatin mediates activation of nicotinamide adenine dinucleotide …

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

PD Brown, S Pugh, NN Laack, JS Wefel… - Neuro …, 2013 - academic.oup.com
Background To determine the protective effects of memantine on cognitive function in
patients receiving whole-brain radiotherapy (WBRT). Methods Adult patients with brain …

[HTML][HTML] Cognitive impairment associated with cancer: a brief review

JC Pendergrass, SD Targum… - Innovations in clinical …, 2018 - ncbi.nlm.nih.gov
This brief review explores the areas of cognitive impairment that have been observed in
cancer patients and survivors, the cognitive assessment tools used, and the management of …

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

AB Lassman, SL Pugh, TJC Wang, K Aldape… - Neuro …, 2023 - academic.oup.com
Background Approximately 50% of newly diagnosed glioblastomas (GBMs) harbor
epidermal growth factor receptor gene amplification (EGFR-amp). Preclinical and early …

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 …

PW Sperduto, ST Chao, PK Sneed, X Luo, J Suh… - International Journal of …, 2010 - Elsevier
PURPOSE: Controversy endures regarding the optimal treatment of patients with brain
metastases (BMs). Debate persists, despite many randomized trials, perhaps because BM …